ストックスクリーナーアプリを入手
0.1856
3.23%
0.0058
アフターアワーズ：
.19
0.0044
+2.37%
前日終値:
$0.1798
開ける：
$0.1847
24時間の取引高:
106.03M
Relative Volume:
11.03
時価総額：
$8.33M
収益：
-
当期純損益:
$-9.88M
株価収益率:
-0.5093
EPS:
-0.3644
ネットキャッシュフロー:
$-9.98M
1週間 パフォーマンス:
+0.87%
1か月 パフォーマンス:
-20.34%
6か月 パフォーマンス:
-84.66%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$0.1792
$0.2443
1週間の範囲:
$0.1766
$0.2443
52週間の値動き範囲:
$0.1592
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Compare LIMN vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
0.1856 | 8.07M | 0 | -9.88M | -9.98M | -0.3644 |
VRTX
Vertex Pharmaceuticals Inc
|
441.70 | 113.01B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
753.93 | 79.87B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
840.87 | 51.51B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
333.39 | 45.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
319.94 | 34.41B | 5.36B | 287.73M | 924.18M | 2.5229 |
Liminatus Pharma Inc (LIMN) 最新ニュース
Quarterly Recap: What is the cash position of Liminatus Pharma Inc2026 Trade Ideas & Free Reliable Trade Execution Plans - baoquankhu1.vn
Earnings Report: Is Liminatus Pharma Inc Equity Warrant stock undervalued right nowTrade Volume Report & Verified Stock Trade Ideas - baoquankhu1.vn
Resistance Check: Can INNOVATE Corp stock outperform in a bear marketEarnings Growth Report & High Accuracy Swing Entry Alerts - baoquankhu1.vn
Quarterly Earnings: Can NRDS be recession proofGlobal Markets & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Update Recap: Will SOBR outperform during market rallies2026 Performance Recap & Reliable Breakout Forecasts - baoquankhu1.vn
Breakout Move: Can Liminatus Pharma Inc Equity Warrant reach resistance levels soonFed Meeting & Weekly Top Performers Watchlists - baoquankhu1.vn
LIMN Rebounds Close to Support Level, Yet Downward Trend Remains Firm - Bitget
Growth Value: Is Liminatus Pharma Inc forming a breakout pattern2026 Patterns & Entry Point Strategy Guides - baoquankhu1.vn
Retail Trends: Whats the fair value of Liminatus Pharma Inc Equity Warrant stock2026 Intraday Action & Weekly Sector Rotation Insights - baoquankhu1.vn
Liminatus Pharma 2025 Annual Report: Pre-Clinical Cancer Therapy Pipeline, Strategy, and Risk Overview - Minichart
Liminatus Pharma 2025 10-K — $0 Revenue, Net Loss $10.21M - TradingView — Track All Markets
Liminatus Pharma (NASDAQ: LIMN) faces cash strain, dilution and Nasdaq listing risks - Stock Titan
Liminatus Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Insider Trends: Is Liminatus Pharma Inc stock a smart retirement pick2026 PreEarnings & Weekly Return Optimization Plans - baoquankhu1.vn
FOMO Trade: Is Liminatus Pharma Inc a good ESG investment2026 Momentum & Capital Efficient Trading Techniques - baoquankhu1.vn
Institution Moves: Is Liminatus Pharma Inc stock a top performer YTD2026 Buyback Activity & Stepwise Trade Execution Plans - baoquankhu1.vn
Liminatus Pharma, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Jobs Data: What are the future prospects of Liminatus Pharma Inc Equity WarrantTrade Analysis Report & AI Driven Price Predictions - baoquankhu1.vn
Fundamentals Check: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interest2026 Breakouts & Daily Profit Focused Stock Screening - baoquankhu1.vn
Moving Averages: What are Liminatus Pharma Incs recent SEC filings showingJobs Report & Verified Momentum Stock Alerts - baoquankhu1.vn
LIMN Stock Price, Quote & Chart | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
Weekly Earnings: Is Liminatus Pharma Inc Equity Warrant stock undervalued right nowMarket Activity Summary & Fast Gaining Stock Strategy Reports - baoquankhu1.vn
Aug Patterns: Can BPMC maintain its current growth rate2026 Fundamental Recap & Accurate Technical Buy Alerts - baoquankhu1.vn
Liminatus eyes clinic with CD47-blockade antibody IBA-101 - BioWorld MedTech
Liminatus Pharma to initiate Phase 1 clinical trial for IBA101 antibody - TipRanks
Liminatus Pharma’s IBA101 May Represent the CD47 Innovation Addressing Anemia and Thrombocytopenia in Advanced Immuno-Oncology - Bitget
Liminatus Pharma announces planned phase 1 clinical trial of IBA101, a next-generation CD47 blocking antibody - marketscreener.com
Liminatus Pharma Announces Planned Phase 1 Clinical Trial of IBA101, a Next-Generation CD47 Blocking Antibody - The Manila Times
Liminatus Pharma Announces Planned Phase 1 Clinical Trial Of Iba101, A Next-Generation Cd47 Blocking Antibody - TradingView
New 'don't-eat-me' cancer antibody to be tested in Liminatus lung trial - Stock Titan
Aug Movers: Is Liminatus Pharma Inc stock a top performer YTD2026 Trends & Smart Money Movement Tracker - baoquankhu1.vn
Reviewing Athira Pharma (NASDAQ:LONA) and Liminatus Pharma (NASDAQ:LIMN) - Defense World
Insider Trends: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestWeekly Trade Recap & Reliable Volume Spike Alerts - baoquankhu1.vn
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN
Aug Mood: Is Liminatus Pharma Inc a strong growth stock2026 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
How Liminatus Pharma Inc. stock responds to policy changesQuarterly Earnings Report & Expert Curated Trade Setup Alerts - Naître et grandir
Winners Losers: Is Liminatus Pharma Inc Equity Warrant subject to activist investor interestJuly 2025 Drop Watch & Weekly Momentum Picks - baoquankhu1.vn
Liminatus Pharma Lowers Quorum Requirement in Bylaw Amendment - TipRanks
Aug Update: Is Liminatus Pharma Inc stock a smart retirement pickJuly 2025 Retail & Reliable Entry Point Trade Alerts - baoquankhu1.vn
LIMN Earnings History & Surprises | EPS & Revenue Results | LIMINATUS PHARMA INC-CL A (NASDAQ:LIMN) - ChartMill
Liminatus Pharma (NASDAQ: LIMN) lowers quorum for shareholder votes - Stock Titan
LIMN Should I Buy - Intellectia AI
Basic earnings per share (basic EPS) of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Liminatus Pharma Inc. (NASDAQ:LIMN) Short Interest Up 4,357.6% in February - Defense World
LIMN PE Ratio & Valuation, Is LIMN Overvalued - Intellectia AI
Free float of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Critical Analysis: Liminatus Pharma (NASDAQ:LIMN) and Athira Pharma (NASDAQ:LONA) - Defense World
Net income of Liminatus Pharma, Inc. – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Dividends – NASDAQ:LIMNW - TradingView
Liminatus Pharma, Inc. Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation - The Ames Tribune
Aug EndMonth: What are Liminatus Pharma Incs recent SEC filings showingQuarterly Profit Report & Accurate Entry and Exit Point Alerts - baoquankhu1.vn
Liminatus Pharma Inc (LIMN) 財務データ
収益
当期純利益
現金流量
EPS
2.69%
0.25%
大文字化:
|
ボリューム (24 時間):